Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization.

Chantharit, Prawat; Tantasawat, Montira; Kasai, Hidefumi; Tanigawara, Yusuke

Chantharit, Prawat; Tantasawat, Montira; Kasai, Hidefumi; Tanigawara, Yusuke.

Affiliation

Chantharit P; Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Tokyo, Japan.
Tantasawat M; Deparment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University; and.
Kasai H; Department of Clinical Pharmacy, Faculty of Pharmacy, Srinakharinwirot University, Bangkok, Thailand.
Tanigawara Y; Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University School of Medicine, Tokyo, Japan.

Ther Drug Monit ; 42(6): 872-879, 2020 12.

Article in En | MEDLINE | ID: mdl-32947557

Subject(s)

Antifungal Agents; Aspergillosis; Voriconazole/pharmacokinetics; Antifungal Agents/administration & dosage; Antifungal Agents/pharmacokinetics; Aspergillosis/drug therapy; Humans; Retrospective Studies; Serum Albumin; Voriconazole/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspergillosis / Voriconazole / Antifungal Agents Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Ther Drug Monit Year: 2020 Document type: Article Affiliation country: Japan Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google